Dr Jesse Dawson

  • Reader (Institute of Cardiovascular and Medical Sciences)
  • Associate (School of Medicine, Dentistry and Nursing)

Biography

I am a Clinical Reader who specialises in clinical stroke research and I work as a Honorary Consultant in the new Queen Elizabeth University Hopsital. My research portfolio includes complex clinical trials in stroke survivors and large multi-centre trials. My main interest is in long-term outcome after stroke. I hold a BHF/Stroke Association programme grant, HTA NIHR funding and NIH funding. I am a member of a Whitehall Research Ethics Committee, the editorial board of Stroke and a grant review panels for the Stroke Association. I also regularly review grants and reports for major funders including the NIHR. and have forged substantial international collaborations. I am medical outcomes manager for 2 pivotal phase III NIH funded studies, an EU FP-7 funded study and other international trials. My trials are among the fastest recruiting studies in the UK Clinical Research Network (Stroke).

Research interests

Leader: Stroke Research

I am currently researching the role of xanthine oxidase inhibition as a novel preventative treatment after stroke. This is the focus of a UK wide clinical trial, funded by a programme grant from the BHF/Stroke Association.

I am also studying novel treatments for upper limb weakness after stroke, including vagus nerve stimulation and robotic therapy. These studies included a large NIHR funded study, funding from Chest Heart Stroke Scotland and a collaboration with industry. 

I am currently Medical Outcomes Manager for the endpoint committee of the large NIH funded CLEAR III trial, the NIH funded MISTIE III study, the European Union FP-7 funded EuroHYP study and the international SITSOPEN collaboration. This involves review of all trial endpoints and co-ordination of the endpoint adjudication process for these large phase III studies.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • MISTIE III
    National Institute of Health
    2015 - 2016
     
  • KRUK Fellowship: Understanding and reducing the risk of cerebrovascular disease in patients with end stage renal disease; from the patient to the population
    Kidney Research UK
    2015 - 2017
     
  • Assessing Cognitive FUnction and MEasuring Cerebral CirculatioN on HaemoDialysis(ACUMEN-HD)
    Darlinda's Charity for Renal Disease
    2015 - 2017
     
  • MISTIE III
    National Institute of Health
    2014 - 2015
     
  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR 3)
    National Institute of Health
    2014 - 2015
     
  • RATULS: Robot assisted training for the upper limb after stroke.
    Health Technology Assessment
    2014 - 2019
     
  • A new urinary biomarker for stroke
    Medical Research Council
    2014 - 2015
     
  • Xanthine oxidase inhibition for improvement of Long-term Outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST)
    Stroke Association
    2014 - 2019
     
  • MISTIE III
    National Institute of Health
    2013 - 2014
     
  • Robotic Therapy Early After Stroke Events (RTEASE).
    Chest, Heart & Stroke, Scotland
    2012 - 2015
     
  • EuroHyp
    European Commission
    2012 - 2017
     
  • Proteomics and Metabolomics to Help Understand and Improve Recovery in Stroke Survivors.
    The RS Macdonald Charitable Trust
    2012 - 2013
     
  • The iomarkers in Stroke Programme; Detecting, Understanding, and Predicting Outcome After Stroke (ISSF Catalyst Fund)
    Wellcome Trust
    2011 - 2014
     
  • Allopurinol and Cerebral Ischaemia; Developing a Model for a Future Clinical Trial
    NHS Greater Glasgow and Clyde
    2011 - 2013
     
  • Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III
    National Institute of Health
    2009 - 2013
     
  • The effect of allopurinol on carotid intima-media thickness and markers of endothelial function in patients with recent stroke - a pilot study
    The Stroke Association
    2009 - 2012
     
  • The Impact of Intraventricular Haemorrhage on Functional Outcomes and Economic Cost of Stroke.
    The Stroke Association
    2009 - 2010
     
  • Central adjudication of modified Rankin scale disability assessments in acute stroke trials
    Scottish Executive Health Department
    2009 - 2010
     
  • Endowment Fellowship
    NHS Greater Glasgow & Clyde West Research Endowment Fund
    2007 - 2008
     
  • Aspirin resistance and microemboli - towards targeted antiplatelet treatment
    Chest, Heart & Stroke, Scotland
    2006 - 2008
     

Teaching

I supervise several PhD and MD students, including students with competative government and charitable funded fellowships. I co-direct a large MSc programme in Clinical Pharmacology and am Director of the Vertical Theme for Clinical Pharmacology and Therapeutics for the MBChB programme. I am a regular MRCP PACES examiner and external higher degree examiner for several UK univeristies.

Publications

List by: Type | Date

Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2004
Number of items: 74.

2016

Findlay, M. D. et al. (2016) Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation, (doi:10.1111/ctr.12765) (PMID:27218240) (In Press)

Al-Alshaikh, S., Quinn, T., Dunn, W., Walters, M., and Dawson, J. (2016) Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses. European Stroke Journal, 1(2), pp. 65-75. (doi:10.1177/2396987316647187)

Al AlShaikh, S., Quinn, T., Dunn, W., Walters, M., and Dawson, J. (2016) Multimodal interventions to enhance adherence to secondary preventive medication after stroke: a systematic review and meta-analyses. Cardiovascular Therapeutics, 34(2), pp. 85-93. (doi:10.1111/1755-5922.12176)

Robson, R., Lacey, A. S., Luzio, S. D., Van Woerden, H., Heaven, M. L., Wani, M., Halcox, J. P. J., Castilla-Guerra, L., Dawson, J., and Hewitt, J. (2016) HbA1c measurement and relationship to incident stroke. Diabetic Medicine, 33(4), pp. 459-462. (doi:10.1111/dme.13057) (PMID:26683404)

Hewitt, J., Walters, M., Padmanabhan, S., and Dawson, J. (2016) Cohort profile of the UK Biobank: diagnosis and characteristics of cerebrovascular disease. BMJ Open, 6(3), e009161. (doi:10.1136/bmjopen-2015-009161) (PMID:27006341) (PMCID:PMC4809076)

MacIsaac, R., Janek, S., Higgins, P., Walters, M. R., Padmanabhan, S., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension, 67(3), pp. 535-540. (doi:10.1161/HYPERTENSIONAHA.115.06344) (PMID:26865199) (Early Online Publication)

Khan, A. A., Quinn, T. J., Hewitt, J., Fan, Y., and Dawson, J. (2016) Serum uric acid level, and association with cognitive impairment and dementia: systematic review and meta-analysis. Age, 38, 16. (doi:10.1007/s11357-016-9871-8) (PMID:26820749)

Dawson, J. (2016) Vagus nerve stimulation and upper limb rehabilitation. Current Physical Medicine and Rehabilitation Reports, (Accepted for Publication)

2015

Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., and Mancia, G. (2015) Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension, 33(9), pp. 1729-1741. (doi:10.1097/HJH.0000000000000701) (PMID:26136207)

Findlay, M. D., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G., Patel, R. K., Stevens, K. K., Geddes, C. C., Dawson, J., and Mark, P. B. (2015) Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients. Stroke, 46(9), pp. 2477-2481. (doi:10.1161/STROKEAHA.115.009095) (PMID:26230856)

Schanstra, J.P. et al. (2015) Diagnosis and prediction of CKD progression by assessment of urinary peptides. Journal of the American Society of Nephrology, 26(8), pp. 1999-2010. (doi:10.1681/asn.2014050423) (PMID:25589610) (PMCID:PMC4520165)

Fulton, R. L., Walters, M. R., Morton, R., Touyz, R. M., Dominiczak, A. F., Morrison, D. S., Padmanabhan, S., Meredith, P. A., McInnes, G. T., and Dawson, J. (2015) Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension, 65(5), 1008-U596. (doi:10.1161/HYPERTENSIONAHA.114.04945) (PMID:25801870)

2014

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953) (PMID:25135183)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J., Macfarlane, P. W., McArthur, K., Langhorne, P., and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi:10.1161/STROKEAHA.114.005405)

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K.R., Tyrrell, P.J., and Smith, C.J. (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke, 45(2), pp. 520-526. (doi:10.1161/STROKEAHA.113.003433)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9), pp. 563-570. (doi:10.1093/eurheartj/eht539)

2013

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Goodfellow, J.A., Dawson, J., and Quinn, T.J. (2013) Management of blood pressure in acute stroke. Expert Review of Neurotherapeutics, 13(8), pp. 911-923. (doi:10.1586/14737175.2013.814964)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1), pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Ziai, W. C. et al. (2013) A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). International Journal of Stroke, 9(4), pp. 536-542. (doi:10.1111/ijs.12097)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Marshall, S., Fearon, P., Dawson, J., and Quinn, T.J. (2013) Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 13(1), pp. 29-42. (doi:10.1586/ERP.12.79)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7), pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Higgins, P., Macfarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi:10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

2012

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4), pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5), e35879. (doi:10.1371/journal.pone.0035879)

2011

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6), e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4), pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Dawson, J., and McArthur, K. (2011) Under the weather with stroke before more data emerge - reply. International Journal of Stroke, 6(1), p. 90. (doi:10.1111/j.1747-4949.2010.00546.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi:10.1038/nnano.2011.5)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342, d1938. (doi:10.1136/bmj.d1938)

Stewart, K., Walters, M., and Dawson, J. (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Heart, 97(7), pp. 585-586. (doi:10.1136/hrt.2010.219717)

2010

Harrison, J.K., Sloan, B., Dawson, J., Lees, K.R., and Morrison, D.S. (2010) The ABCD and ABCD2 as predictors of stroke in transient ischemic attack clinic outpatients: a retrospective cohort study over 14 years. Quarterly Journal of Medicine, 103(9), pp. 679-685. (doi:10.1093/qjmed/hcq108)

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3), pp. 18-21.

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2), pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36), pp. 4578-4586. (doi:10.2174/092986710794182962)

2009

Quinn, T.J., and Dawson, J. (2009) Acute `strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5), pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x) (PMID:19659822)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2), pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1), pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1), pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1), pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3), pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6), e468-e468. (doi:10.1161/STROKEAHA.109.551077) (PMID:19390063)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3), pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10), pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

2008

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., and Lees, K.R. (2008) Past, present and future of alteplase for acute ischemic stroke. Expert Review of Neurotherapeutics, 8(2), pp. 181-192. (doi:10.1586/14737175.8.2.181)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2), pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011)

Christensen, M., Dawson, J., and Vincent, C. (2008) Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Advances in Therapy, 25(9), pp. 831-841. (doi:10.1007/s12325-008-0092-0)

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1), e9-e9. (doi:10.1161/STROKEAHA.107.502245)

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5), e89-e89. (doi:10.1161/STROKEAHA.108.515635)

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2), pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x)

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1), pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11), pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12), pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

2007

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11), e144. (doi:10.1161/STROKEAHA.107.490110)

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6), pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., and Lees, K.R. (2007) Advances in emerging therapies 2006. Stroke, 38(2), pp. 219-221. (doi:10.1161/01.STR.0000254718.22566.90)

Dawson, J., Lees, K.R., and Quinn, T.J. (2007) Acute stroke: we have the treatments and we have the evidence we need to use them. Critical Care Medicine, 11(2), p. 124.

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17), pp. 1879-1886.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8), pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

2004

Briggs, A., Sculpher, M., Dawson, J., Fitzpatrick, R., Murray, D., and Malchau, H. (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3(2), pp. 78-79.

This list was generated on Wed Jul 27 01:13:33 2016 BST.
Number of items: 74.

Articles

Findlay, M. D. et al. (2016) Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation, (doi:10.1111/ctr.12765) (PMID:27218240) (In Press)

Al-Alshaikh, S., Quinn, T., Dunn, W., Walters, M., and Dawson, J. (2016) Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses. European Stroke Journal, 1(2), pp. 65-75. (doi:10.1177/2396987316647187)

Al AlShaikh, S., Quinn, T., Dunn, W., Walters, M., and Dawson, J. (2016) Multimodal interventions to enhance adherence to secondary preventive medication after stroke: a systematic review and meta-analyses. Cardiovascular Therapeutics, 34(2), pp. 85-93. (doi:10.1111/1755-5922.12176)

Robson, R., Lacey, A. S., Luzio, S. D., Van Woerden, H., Heaven, M. L., Wani, M., Halcox, J. P. J., Castilla-Guerra, L., Dawson, J., and Hewitt, J. (2016) HbA1c measurement and relationship to incident stroke. Diabetic Medicine, 33(4), pp. 459-462. (doi:10.1111/dme.13057) (PMID:26683404)

Hewitt, J., Walters, M., Padmanabhan, S., and Dawson, J. (2016) Cohort profile of the UK Biobank: diagnosis and characteristics of cerebrovascular disease. BMJ Open, 6(3), e009161. (doi:10.1136/bmjopen-2015-009161) (PMID:27006341) (PMCID:PMC4809076)

MacIsaac, R., Janek, S., Higgins, P., Walters, M. R., Padmanabhan, S., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension, 67(3), pp. 535-540. (doi:10.1161/HYPERTENSIONAHA.115.06344) (PMID:26865199) (Early Online Publication)

Khan, A. A., Quinn, T. J., Hewitt, J., Fan, Y., and Dawson, J. (2016) Serum uric acid level, and association with cognitive impairment and dementia: systematic review and meta-analysis. Age, 38, 16. (doi:10.1007/s11357-016-9871-8) (PMID:26820749)

Dawson, J. (2016) Vagus nerve stimulation and upper limb rehabilitation. Current Physical Medicine and Rehabilitation Reports, (Accepted for Publication)

Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., and Mancia, G. (2015) Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension, 33(9), pp. 1729-1741. (doi:10.1097/HJH.0000000000000701) (PMID:26136207)

Findlay, M. D., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G., Patel, R. K., Stevens, K. K., Geddes, C. C., Dawson, J., and Mark, P. B. (2015) Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients. Stroke, 46(9), pp. 2477-2481. (doi:10.1161/STROKEAHA.115.009095) (PMID:26230856)

Schanstra, J.P. et al. (2015) Diagnosis and prediction of CKD progression by assessment of urinary peptides. Journal of the American Society of Nephrology, 26(8), pp. 1999-2010. (doi:10.1681/asn.2014050423) (PMID:25589610) (PMCID:PMC4520165)

Fulton, R. L., Walters, M. R., Morton, R., Touyz, R. M., Dominiczak, A. F., Morrison, D. S., Padmanabhan, S., Meredith, P. A., McInnes, G. T., and Dawson, J. (2015) Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension, 65(5), 1008-U596. (doi:10.1161/HYPERTENSIONAHA.114.04945) (PMID:25801870)

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi:10.1161/HYPERTENSIONAHA.114.03953) (PMID:25135183)

Goldie, F. C., Fulton, R. L., Dawson, J., Bluhmki, E., and Lees, K. R. (2014) Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. International Journal of Stroke, 9(6), pp. 755-758. (doi:10.1111/ijs.12131)

Higgins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi:10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J., Macfarlane, P. W., McArthur, K., Langhorne, P., and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi:10.1161/STROKEAHA.114.005405)

Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K.R., Tyrrell, P.J., and Smith, C.J. (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke, 45(2), pp. 520-526. (doi:10.1161/STROKEAHA.113.003433)

McCallum, L. et al. (2014) Response to effect of serum chloride on mortality in hypertensive patients. Hypertension, 63(3), e15-e15. (doi:10.1161/HYPERTENSIONAHA.113.02926)

Williamson, C. et al. (2014) Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. European Heart Journal, 35(9), pp. 563-570. (doi:10.1093/eurheartj/eht539)

McCallum, L. et al. (2013) Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension, 62(5), pp. 836-843. (doi:10.1161/HYPERTENSIONAHA.113.01793)

Goodfellow, J.A., Dawson, J., and Quinn, T.J. (2013) Management of blood pressure in acute stroke. Expert Review of Neurotherapeutics, 13(8), pp. 911-923. (doi:10.1586/14737175.2013.814964)

Aubini è re-Robb, L. et al. (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension, 62(1), pp. 190-196. (doi:10.1161/HYPERTENSIONAHA.111.00686)

Ziai, W. C. et al. (2013) A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). International Journal of Stroke, 9(4), pp. 536-542. (doi:10.1111/ijs.12097)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi:10.1161/STROKEAHA.112.670653)

Marshall, S., Fearon, P., Dawson, J., and Quinn, T.J. (2013) Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 13(1), pp. 29-42. (doi:10.1586/ERP.12.79)

Dawson, J. et al. (2013) Acetaminophen use and change in blood pressure in a hypertensive population. Journal of Hypertension, 31(7), pp. 1485-1490. (doi:10.1097/HJH.0b013e328360f6f8)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Higgins, P., Macfarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi:10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D., Quinn, T., Higgins, P., Langhorne, P., Walters, M.R., Weir, C.J., Dawson, J., and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi:10.1161/STROKEAHA.113.002266)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi:10.1161/HYPERTENSIONAHA.112.191510)

Dawson, J., Quinn, T., Lees, K.R., and Walters, M.R. (2012) Microembolic signals and aspirin resistance in patients with carotid stenosis. Cardiovascular Therapeutics, 30(4), pp. 234-239. (doi:10.1111/j.1755-5922.2010.00259.x)

Higgins, P., Dawson, J., Lees, K.R., McArthur, K., Quinn, T.J., and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi:10.1111/j.1755-5922.2011.00277.x)

Dawson, J., Walters, M., Delles, C., Mischak, H., and Mullen, W. (2012) Urinary proteomics to support diagnosis of stroke. PLoS ONE, 7(5), e35879. (doi:10.1371/journal.pone.0035879)

Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Sugar and stroke: cerebrovascular disease and blood glucose control. Cardiovascular Therapeutics, 29(6), e31-e42. (doi:10.1111/j.1755-5922.2010.00166.x)

Cameron, A., Dawson, J., Quinn, T.J., Walters, M.R., McInnes, G.T., Morrison, D., Sloan, W., and Lees, K.R. (2011) Long-term outcome following attendance at a transient ischemic attack clinic. International Journal of Stroke, 6(4), pp. 306-311. (doi:10.1111/j.1747-4949.2011.00591.x)

Dawson, J., and McArthur, K. (2011) Under the weather with stroke before more data emerge - reply. International Journal of Stroke, 6(1), p. 90. (doi:10.1111/j.1747-4949.2010.00546.x)

Higgins, P., Dawson, J., and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi:10.1038/nnano.2011.5)

McArthur, K.S., Quinn, T.J., Dawson, J., and Walters, M.R. (2011) Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase. British Medical Journal, 342, d1938. (doi:10.1136/bmj.d1938)

Stewart, K., Walters, M., and Dawson, J. (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Heart, 97(7), pp. 585-586. (doi:10.1136/hrt.2010.219717)

Harrison, J.K., Sloan, B., Dawson, J., Lees, K.R., and Morrison, D.S. (2010) The ABCD and ABCD2 as predictors of stroke in transient ischemic attack clinic outpatients: a retrospective cohort study over 14 years. Quarterly Journal of Medicine, 103(9), pp. 679-685. (doi:10.1093/qjmed/hcq108)

Quinn, T.J., Dawson, J., and Walters, M. (2010) Equality of access to “fast-track” stroke services in an older, socio-economically deprived Scottish population. Scottish Medical Journal, 55(3), pp. 18-21.

Dawson, J., Quinn, T.J., Rafferty, M., Higgins, P., Ray, G., Lees, K.R., and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi:10.1111/j.1755-5922.2010.00188.x)

McArthur, K., Dawson, J., and Walters, M. (2010) What is it with the weather and stroke? Expert Review of Neurotherapeutics, 10(2), pp. 243-249. (doi:10.1586/ERN.09.154)

Rafferty, M., Walters, M.R., and Dawson, J. (2010) Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant? Current Medicinal Chemistry, 17(36), pp. 4578-4586. (doi:10.2174/092986710794182962)

Quinn, T.J., and Dawson, J. (2009) Acute `strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi:10.1586/erp.09.63)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., and Walters, M. (2009) The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. British Journal of Clinical Pharmacology, 68(5), pp. 662-668. (doi:10.1111/j.1365-2125.2009.03497.x)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Functional outcome measures in contemporary stroke trials. International Journal of Stroke, 4(3), pp. 200-205. (doi:10.1111/j.1747-4949.2009.00271.x) (PMID:19659822)

Dawson, J., Lees, K., Weir, C., Weir, C., Quinn, T., Ali, M., Hennerici, M., and Walters, M. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Ischemic Stroke. Cerebrovascular Diseases, 28(2), pp. 202-203.

Dawson, J., Quinn, T., and Walters, M. (2009) Under the weather with stroke; more data emerge. International Journal of Stroke, 4(1), pp. 19-20.

Dawson, J., Lamb, K.E., Quinn, T.J., Lees, K.R., Horvers, M., Verrijth, M.J., and Walters, M. (2009) A recognition tool for transient ischaemic attack. QJM: An International Journal of Medicine, 102(1), pp. 43-49. (doi:10.1093/qjmed/hcn139)

Dawson, J., Quinn, T.J., Harrow, C., Lees, K.R., Weir, C., Cleland, S., and Walters, M. (2009) Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes. Diabetes Care, 32(1), pp. 135-137. (doi:10.2337/dc08-1179)

Quinn, T.J., Cameron, A., Dawson, J., Lees, K.R., and Walters, M.R. (2009) ABCD2 scores and prediction of noncerebrovascular diagnoses in an outpatient population: a case-control study. Stroke, 40(3), pp. 749-753. (doi:10.1161/STROKEAHA.108.530444)

Quinn, T.J., Cameron, A.D., Dawson, J., Walters, M., and Lees, K.R. (2009) A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic response. Stroke, 40(6), e468-e468. (doi:10.1161/STROKEAHA.109.551077) (PMID:19390063)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Exploring the reliability of the modified Rankin Scale. Stroke, 40(3), pp. 762-766. (doi:10.1161/STROKEAHA.108.522516)

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke, 40(10), pp. 3393-3395. (doi:10.1161/STROKEAHA.109.557256)

Muir, S.W., Harrow, C., Dawson, J., Lees, K.R., Weir, C.J., Sattar, N., and Walters, M.R. (2008) Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke, 39(12), pp. 3303-3307. (doi:10.1161/STROKEAHA.108.519793)

Quinn, T.J., Dawson, J., and Lees, K.R. (2008) Past, present and future of alteplase for acute ischemic stroke. Expert Review of Neurotherapeutics, 8(2), pp. 181-192. (doi:10.1586/14737175.8.2.181)

Quinn, T.J., Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., and Lees, K.R. (2008) Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials. Stroke, 39(1), pp. 231-233. (doi:10.1161/STROKEAHA.107.493320)

Ahmad, F., Quinn, T., Dawson, J., and Walters, M. (2008) A link between lunar phase and medically unexplained stroke symptoms: An unearthly influence? Journal of Psychosomatic Research, 65(2), pp. 131-133. (doi:10.1016/j.jpsychores.2008.05.011)

Christensen, M., Dawson, J., and Vincent, C. (2008) Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Advances in Therapy, 25(9), pp. 831-841. (doi:10.1007/s12325-008-0092-0)

Dawson, J., Quinn, T.J., Lees, K.R., and Walters, M. (2008) The continued yin and yang of uric acid. Stroke, 39(1), e9-e9. (doi:10.1161/STROKEAHA.107.502245)

Dawson, J., Quinn, T.J., and Walters, M. (2008) Uric acid: neuroprotective or neurotoxic? [reply]. Stroke, 39(5), e89-e89. (doi:10.1161/STROKEAHA.108.515635)

Dawson, J., Weir, C., Wright, F., Bryden, C., Aslanyan, S., Lees, K., Bird, W., and Walters, M. (2008) Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland. Acta Neurologica Scandinavica, 117(2), pp. 85-89. (doi:10.1111/j.1600-0404.2007.00916.x)

Quinn, T.J., Dawson, J., and Walters, M. (2008) Dr John Rankin; His life, legacy and the 50th anniversary of the Rankin stroke scale. Scottish Medical Journal, 53(1), pp. 44-47.

Quinn, T.J., Dawson, J., Walters, M., and Lees, K.R. (2008) Variability in modified rankin scoring across a large cohort of observers. Stroke, 39(11), pp. 2975-2979. (doi:10.1161/STROKEAHA.108.515262)

Quinn, T.J., Ray, G., Atula, S., Walters, M.R., Dawson, J., and Lees, K.R. (2008) Deriving modified rankin scores from medical records. Stroke, 39(12), pp. 3421-3423. (doi:10.1161/STROKEAHA.108.519306)

Quinn, T.J., Dawson, J., Walters, M.R., and Lees, K.R. (2007) Reliability of the modified rankin scale. Stroke, 38(11), e144. (doi:10.1161/STROKEAHA.107.490110)

Dawson, J., Lees, J.S., Chang, T.P., Walters, M.R., Ali, M., Davis, S.M., Diener, H.C., and Lees, K.R. (2007) Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke, 38(6), pp. 1893-1898. (doi:10.1161/STROKEAHA.106.472381)

Dawson, J., and Lees, K.R. (2007) Advances in emerging therapies 2006. Stroke, 38(2), pp. 219-221. (doi:10.1161/01.STR.0000254718.22566.90)

Dawson, J., Lees, K.R., and Quinn, T.J. (2007) Acute stroke: we have the treatments and we have the evidence we need to use them. Critical Care Medicine, 11(2), p. 124.

Dawson, J., Quinn, T.J., and Walters, M. (2007) Uric acid reduction: A new paradigm in the management of cardiovascular risk? Current Medicinal Chemistry, 14(17), pp. 1879-1886.

Quinn, T.J., Lees, K.R., Hardemark, H.G., Dawson, J., and Walters, M.R. (2007) Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke, 38(8), pp. 2257-2261. (doi:10.1161/STROKEAHA.106.480723)

Briggs, A., Sculpher, M., Dawson, J., Fitzpatrick, R., Murray, D., and Malchau, H. (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3(2), pp. 78-79.

Conference Proceedings

Kepli, W. M., Fulton, R. L., Walters, M., Ali, M., Bath, P. M., and Dawson, J. (2014) Antiplatelet therapy following ischemic stroke - continue or change pre-existing therapy? In: International Stroke Conference 2014, San Diego, CA, USA, 12-14 Feb 2014, A135.

This list was generated on Wed Jul 27 01:13:33 2016 BST.